Christine Najarian
Physician Assistant · Evergreen Park, ILNPI 1518445543
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 611 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 45 manufacturers reported payments, led by AbbVie at 38.0% of the total. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 611 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Lilly USA, LLC$1K
- AstraZeneca$914
- Amgen$901
- Boehringer Ingelheim$617
- Novo Nordisk$482
- plus $4K from 39 others
What the payments were for
- Food & beverage$13,142100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,142 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 21 | $24,619 |
| OzempicSemaglutide | 15 | $17,847 |
| Repatha SureclickEvolocumab | 12 | $16,233 |
| MounjaroTirzepatide | 13 | $15,078 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,140 |
| JardianceEmpagliflozin | 13 | $9,865 |
| Nebivolol Hcl | 16 | $1,978 |
| Levothyroxine Sodium | 101 | $1,639 |
| Atorvastatin Calcium | 128 | $1,239 |
| Amlodipine Besylate | 89 | $1,110 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 46 | $1,024 |
| Rosuvastatin Calcium | 42 | $774 |
| Losartan Potassium | 75 | $671 |
| Metformin Hcl | 60 | $555 |
| SynthroidLevothyroxine Sodium | 13 | $546 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $914 | $34,75937 claims |
| Novo NordiskOzempic | $482 | $17,84715 claims |
| Lilly USA, LLCMounjaro | $1,176 | $15,07813 claims |
| Boehringer IngelheimJardiance | $617 | $9,86513 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $1,639101 claims |
| AbbVieSynthroid | $4,990 | $54613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Evergreen Park
- Rachel BrucasEvergreen Park$14K
- Jessica SchaferEvergreen Park$14K
- Andrew MastroChicago$419K
- Christopher AricoSkokie$407K
- Karlijn BurridgeWestmont$144K
- Ian MackeySkokie$135K
- Stephanie TraceyItasca$122K
- Olabimpe PhilipsAddison$103K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.